The Effect of Abdominal Binder Use on Postoperative Pain and Mobility in Patients Undergoing Pelvic Surgery

NCT ID: NCT03684304

Last Updated: 2022-05-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-30

Study Completion Date

2021-03-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the effect of post-operative abdominal binder usage on total narcotic usage after undergoing surgery. To determine if abdominal binder usage results in decreased visual analog scale (VAS) pain scores and shorter time to first ambulation post operatively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Organ Prolapse Abdominal Surgery Laparoscopic Surgery Post Operative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control / No Binder

Patients randomized to routine care / no abdominal binder use will not use an abdominal binder during their post operative course.

Group Type NO_INTERVENTION

No interventions assigned to this group

Abdominal binder

Patients randomized abdominal binder use will have an abdominal binder placed on them in the operating room once their surgery has been completed.

Group Type EXPERIMENTAL

Abdominal binder

Intervention Type DEVICE

The abdominal binder is an elastic abdominal compression / support device that will be placed on the patient after surgery has been completed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Abdominal binder

The abdominal binder is an elastic abdominal compression / support device that will be placed on the patient after surgery has been completed.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients must be 18 years or older.
* Willing and able to provide informed consent.
* Patients must be undergoing scheduled pelvic surgery.
* Patients must be admitted overnight (at least one night) after surgery.

Exclusion Criteria

* Patients who are younger than 18 years old.
* Patients who are unable or unwilling to provide informed consent.
* Patients who are illiterate.
* Patients who are non-English speaking or reading.
* Patients who are unwilling to be contacted by phone after surgery.
* Patients who are undergoing pelvic surgery that does not warrant observation or admission after surgery for at least one night.
* Patients who are having surgery for any other indication other than pelvic surgery.
* Patients with a chronic pain syndrome (as evidenced by daily intake of opioids).
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospitals Cleveland Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Caitlin Carlton

Resident Physician, Primary Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospitals

Cleveland, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

binder071718

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.